Essential Partners »

Cartesian Therapeutics shares owned by Essential Partners

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Essential Partners from 13F filings

Historical chart of Essential Partners investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Essential Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Essential Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.7k 597 6.15
2025-09-30 $143 14 10.21
2025-06-30 $156 15 10.40

More positions owned by Essential Partners

Sprott Gold Convert to Physical Cef (PHYS)
Comfort Sys Usa Stock (FIX)
Nvidia Corporation Stock (NVDA)
Schwab Fundamental Int'l Broad Etf (FNDF)
iShares S&P 500 Etf (IVV)
Schwab Fundamental U.S. Broad Etf (FNDB)
Vanguard Short-Term USTS Etf (VGSH)
General Mtrs Stock (GM)
Ge Aerospace Stock (GE)
Merck & Co Stock (MRK)
Technipfmc Stock (FTI)
Ge Vernova Stock (GEV)
Teradyne Stock (TER)
Incyte Corp Stock (INCY)
Pnc Finl Svcs Group Stock (PNC)

View all positions for Essential Partners

Top funds holding Cartesian Therapeutics

Squarepoint Ops
FMR
BlackRock
Vanguard Group
Vanguard Capital Management
683 Capital Management
Millennium Management
Geode Capital Management
Erste Asset Management GmbH
State Street Corporation
Privium Fund Management B.V.
Marshall Wace
Two Sigma Investments
UBS Group
Citadel Advisors

View all funds holding Cartesian Therapeutics